Clinical Trial Update: A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BMS-986177 for prevention of stroke in patients on aspirin and clopidogrel has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• BMS-986177

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Acute Ischemic Stroke, Transient Ischemic Attack (TIA) | Phase 2 | Status: COMPLETED | Results posted: 2023-06-12